The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Everolimus (EVE) in advanced, nonfunctional, well-differentiated neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin: Second interim overall survival (OS) results from the RADIANT-4 study.
 
James C. Yao
Consulting or Advisory Role - Eisai; Ipsen; Merck; Novartis
Research Funding - Advanced Accelerator Applications (Inst); Novartis (Inst)
 
Nicola Fazio
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Celgene; Ipsen; Lexicon; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Simron Singh
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Roberto Buzzoni
Research Funding - Italfarmaco (Inst); Novartis (Inst); Otsuka (Inst)
Travel, Accommodations, Expenses - Ipsen; Italfarmaco; Novartis
 
Carlo Carnaghi
No Relationships to Disclose
 
Edward M. Wolin
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis
 
Jiri Tomasek
Honoraria - Novartis
Patents, Royalties, Other Intellectual Property - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Markus Raderer
Honoraria - Celgene; Ipsen; Novartis; Roche
Consulting or Advisory Role - Celgene; Ipsen; Novartis; Roche
 
Harald Lahner
Honoraria - Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Maurizio Voi
Employment - Mesoblast (I); Novartis
Stock and Other Ownership Interests - Novartis
 
Lida Bubuteishvili-Pacaud
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jeremie Lincy
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Juan W. Valle
Honoraria - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Novartis; Sirtex Medical
Speakers' Bureau - Abbott Nutrition; Celgene; Ipsen; Novartis; Pfizer; Sirtex Medical
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Gianfranco Delle Fave
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Do-Youn Oh
Consulting or Advisory Role - AstraZeneca; Baxalta; Lilly; Merck; Novartis
Research Funding - Mogam Biotechnology Research Institue (Inst)
 
Jonathan R. Strosberg
Honoraria - Novartis
Consulting or Advisory Role - Lexicon; Novartis
Speakers' Bureau - Genentech; Ipsen
Research Funding - Novartis; Pharmacyclics
 
Matthew H. Kulke
Consulting or Advisory Role - Ipsen; Novartis
 
Marianne E. Pavel
Honoraria - Ipsen; Lexicon; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Lexicon; Novartis; Pfizer
Research Funding - Ipsen (Inst); Novartis (Inst)